Home › Funds › First Pacific Advisors, LP › BIO

First Pacific Advisors, LP position in BIO

BIO RAD LABS INC · Industrials

First Pacific Advisors, LP reported holding 269,082 shares of BIO (BIO RAD LABS INC) in its Q3 2026 13F filing — a position valued at US$101.6M, representing 1.21% of its reported portfolio and ranking #32 among its reported holdings. First Pacific Advisors, LP has disclosed BIO holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)269.08K sh
Reported value held$101.63M
Portfolio Weight1.21%
First reportedQ4 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How First Pacific Advisors, LP's BIO position evolved

First Pacific Advisors, LP first disclosed a stake in BIO in Q4 2023 at 4,866 shares (US$1.6M). The position peaked in Q4 2025 at 401,457 shares, worth US$121.6M. Across 12 filings, First Pacific Advisors, LP increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 269,082 shares valued at US$101.6M — a reduction of -132,779 shares quarter over quarter.. Notable position changes include a 2052% increase in Q1 2024 (shares fell 21% over the following quarter), a 53% increase in Q2 2024 (shares rose 23% over the following quarter), a 136% increase in Q1 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 4.87K $1.57M New
Q1 2024 104.74K $36.23M Add
Q2 2024 160.55K $43.85M Add
Q3 2024 157.88K $52.82M Reduce
Q4 2024 157.85K $51.86M Hold
Q1 2025 372.56K $90.74M Add
Q2 2025 386.95K $93.38M Add
Q3 2025 394.41K $110.59M Add
Q4 2025 401.46K $121.64M Add
Q1 2026 407.36K $113.55M Add
Q2 2026 401.86K $117.99M Reduce
Q3 2026 269.08K $101.63M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIO and 13F data

BIO (BIO RAD LABS INC) is a Industrials company. 24 other funds we track also report a position in BIO — the largest reported positions include First Eagle Investment Management (US$927.5M), ARIEL INVESTMENTS, LLC (US$298.1M), EARNEST PARTNERS LLC (US$214.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIO

All BIO fund holders →

FAQ

How long has First Pacific Advisors, LP held BIO?

First Pacific Advisors, LP has disclosed BIO holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is First Pacific Advisors, LP's current position in BIO?

As of Q3 2026, First Pacific Advisors, LP holds 269.08K shares of BIO (BIO RAD LABS INC), valued at $101.63M, representing 1.21% of its reported portfolio and ranking #32.

Has First Pacific Advisors, LP been buying or selling BIO?

In the latest 13F filing (Q3 2026), First Pacific Advisors, LP reduced its position in BIO. The position peaked in Q4 2025 at 401.46K shares.

Which other funds hold BIO?

Other major institutional holders of BIO include First Eagle Investment Management, ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.